"Damn Good Advice (For People With Talent )" is a look into the mind of one of America's most legendary creative thinkers, George Lois. Offering indispensle lessons, practical advice, facts, anecdotes and inspiration, this book is a timeless creative bible for all those looking to succeed in life, business and creativity. These are key lessons derived from the incomparle life of 'Master Communicator' George Lois, the original Mad Man of Madison Avenue. Written and compiled by the man "The Wall Street Journal" called "prodigy, enfant terrible, founder of agencies, creator of legends," each step is borne from a passion to succeed and a disdain for the status quo.
Organised into inspirational, bite-sized pointers, each page offers fresh insight into the sources of success, from identifying your heroes to identifying yourself. The ideas, images and illustrations presented in this book are fresh, witty and in-your-face. Whether it's communicating your point in nanosecond, creating an explosive portfolio or making your presence felt, no one is better placed than George Lois to teach you the process of creativity.
Poignant, punchy and to-the-point, "Damn Good Advice (For People With Talent )" is a must have for anyone on a quest for success.

Jean-Paul Goude is a modern legend in the world of commercial art. From his New York days with Esquire magazine to his latest work for Galeries Lafayette, he has consistently provoked and delighted those who have encountered his work. He was Grace Jones's Pygmalion, creating unforgettable images of her, from androgyne to cyber-superwoman to supreme diva. This volume, published to accompany a major retrospective at the Musee des Arts Decoratifs in Paris, is a celebration of his creative zest and perfectionism, and his unique affinity for making fresh and engaging work. Around 600 images are on show, including many working documents published here for the first time, from inspired doodles to final images that sparkle with creative vigour. Selected and arranged by Goude himself, they present a gallery of artworks that have redefined advertising and brand photography as we know them. Sexy, irreverent and full of humour, this book will inform and instruct all those concerned with the art of image-making, whether professionals or simply those prepared to be entertained by chic, witty images that work.

George Lois is an American icon in graphic design. This book showcases his logos with his own comments on why they work. A bonus in the book is a chapter of world logos made by others with George Lois's comments on why they are so good. George Lois continues to prove that a memorable brand name interacting with a strong visual symbol to communicate a humanistic idea is the ultimate art form in popular graphic communication. His Big Idea branding and logo design, developed with a built-in, conceptual, "catchy" brand name, can visually impart information in a nanosecond, delivering a specific ethos with a penetrating promise of power that immediately sears a product's virtues into a viewers' brain-and has the potential of bringing instantaneous success. Lois boldly states, "My goal, with the vast majority of the brands I have named and logos I have designed, is to create 'humanistic' symbols, driven by a pregnant idea, visualizing some recognizable aspect of the human experience, and magically relating it to a unique selling proposition that empowers great advertising and promotion." If anyone wants to experience the creation of Big Idea Branding, this astounding compilation of the work of George Lois is the ultimate form of clear, precise, eye-popping communication.

"Precision/personalized or stratified medicine" refers to the tailoring of medical treatment or drug administration to the individual characteristics of each patient treatment. It does not literally mean that a pharmaceutical company makes a drug for an individual patient for consumption and treatment but rather means the ability to stratify (or classify) individuals into sub-populations that differ in their responsiveness to a specific drug. A marker that provides information on the likely response to therapy, i.e., either in terms of tumor shrinkage or survival of the patient is termed "predictive biomarker". Despite their promise in precision medicine and the explosion of knowledge in this area, there is not a single source on this subject that puts all this evidence together in a concise or richly illustrated and easy to understand manner. This book provides a collection of ingeniously organized, well-illustrated and up-to-date authoritative chapters divided into five sections that are clear and easy to understand. Section one provides an overview of biomarkers, introduces the basic terminologies, definitions, technologies, tools and concepts associated with this subject in the form of illustrations/graphics, photographs and concise texts. Several recent biomarker endeavors that have been initiated and funded by the National Cancer Institute, National Institutes of Health, FDA and other International organizations are presented. Section two involves the signaling pathways controlling cell growth and differentiation altered in cancer. This section analyzes how predictive biomarkers are altered (expressed or amplified) across cancer types. Section three explores how predictive biomarkers play a role in patient stratification and tailored treatment in relationship to specific cancers. In addition, it includes discussion on the various precision medicine initiatives that are going on across the globe (e.g. TARGET, NCI-MATCH, BATTLE, SHIVA, etc.). Section four discusses: (a) how pharmaceutical companies validate predictive biomarker assays and accompanying companion diagnostics either internally or externally with partner companies such as central laboratories or clinical research organizations, and (b) how predictive biomarker tests fall under the oversight of US FDA, Centers for Medicare & Medicaid Services (CMS) and state laws. Section five wraps up novel agents and targets that are being used as targets for cancer therapeutics. The biomarkers associated with these protocols will also be presented. Throughout the book, sidebars, special interest boxes and illustrations are used to explain terms that are either newly introduced, uncommon, or specialized. Predictive Biomarkers in Oncology will serve as a definitive guide for practicing pathologists, oncologists, basic researchers, and personnel in the pharmaceutical or diagnostic industry interested in learning how "predictive biomarkers" are used in precision cancer therapy.